Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44

Dirk O Watermann1, Yesheng Tang, Axel Zur Hausen

  • 1Department of Obstetrics and Gynecology, University of Freiburg, Freiburg, Germany.

Cancer Research
|May 3, 2006
PubMed

Insights

The splicing factor Tra2-beta1 enhances CD44 exon inclusion, particularly in breast cancer. Its increased expression in tumors suggests a role in cancer progression and metastasis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • RNA Splicing

Background:

  • The CD44 gene exhibits extensive alternative splicing, involving variable exons crucial for various cellular functions.
  • Aberrant splicing of CD44 is linked to tumor progression and metastasis in several human cancers, including breast cancer.
  • Exon v4 of CD44 contains enhancer sequences essential for its inclusion and binding of specific nucleic acid-binding proteins.

Purpose of the Study:

  • To investigate the role of the serine/arginine-rich (SR) splicing factor human Tra2-beta1 (hTra2-beta1) in the alternative splicing of CD44.
  • To determine if hTra2-beta1 influences the inclusion of CD44 exons v4 and v5.
  • To assess the expression levels of hTra2-beta1 in human breast cancer tissues compared to non-pathologic controls.

Main Methods:

  • In vivo splicing assays were performed to evaluate the effect of hTra2-beta1 on CD44 exon v4 and v5 inclusion.
  • The synergistic effects of hTra2-beta1 with YB-1 protein were examined.
  • Matched pair analysis of human breast cancer and nonpathologic tissue samples was conducted to quantify Tra2-beta1 RNA and protein levels.

Main Results:

  • hTra2-beta1 significantly enhanced the in vivo inclusion of CD44 exons v4 and v5, acting synergistically with YB-1.
  • The enhancer sequence within exon v4 was required for hTra2-beta1-mediated activation.
  • A significant induction of Tra2-beta1 was observed in invasive breast cancer tissues at both RNA and protein levels compared to controls.

Conclusions:

  • hTra2-beta1 plays a key role in promoting the inclusion of CD44 exons v4 and v5, potentially through interaction with enhancer elements.
  • The elevated expression of Tra2-beta1 in breast cancer suggests its involvement in the generation of CD44 isoforms associated with tumor progression.
  • These findings highlight Tra2-beta1 as a potential factor contributing to breast cancer metastasis.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
Pre-mRNA Processing: RNA Splicing01:32

Pre-mRNA Processing: RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...